Use of the IL-6R antagonist tocilizumab in hospitalized COVID-19 patients

J Intern Med. 2021 Mar;289(3):430-433. doi: 10.1111/joim.13163. Epub 2020 Oct 20.

¹ From the Center for Blood Disorders and Stem Cell Transplantation, Swedish Cancer Institute, Swedish Medical Center, Seattle, WA, USA.
² Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
³ Infectious Disease, Swedish Medical Center, Seattle, WA, USA.
⁴ Hospital Medicine, Swedish Medical Center, Seattle, WA, USA.
⁵ Pulmonary and Critical Care, Swedish Medical Center, Seattle, WA, USA.
⁶ US Anesthesia Partners, Seattle, WA, USA.
⁷ Swedish Heart and Vascular Institute, Swedish Medical Center, Seattle, WA, USA.

No abstract available

Publication types